Need professional-grade analysis? Visit stockanalysis.com
$96.40M
N/A
257
N/A
23andMe Holding Co. (MEHCQ) trades on United States in USD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at $3.50.
Over the past year, MEHCQ has traded between a low of $0.55 and a high of $6.12. The stock has gained 169.2% over this period. It is currently 42.8% below its 52-week high.
23andMe Holding Co. has a market capitalization of $96.40M.
23andMe Holding Co. operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally. The company provides personal genome service (PGS) that consists of a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. It also operates Lemonaid telehealth platform to access affiliated licensed healthcare professionals for medical consultation and treatment for various common conditions; offers non-controlled medications for treatment of acute and chronic conditions; and provides Ozempic and Wegovy through its weight loss program, offering consumers with access to affordable weight management care. In addition, the company provides research services. 23andMe Holding Co. was founded in 2006 and is headquartered in San Francisco, California.
Side-by-side comparison against top Healthcare peers.